Axonics(AXNX)
Search documents
Axonics(AXNX) - 2023 Q2 - Quarterly Report
2023-07-30 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...
Axonics(AXNX) - 2023 Q2 - Earnings Call Transcript
2023-07-28 03:27
Call Start: 16:30 January 1, 0000 5:27 PM ET Axonics, Inc. (NASDAQ:AXNX) Q2 2023 Earnings Conference Call July 27, 2023 16:30 ET Company Participants Neil Bhalodkar - Vice President of Investor Relations Raymond Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Officer Conference Call Participants Chris Pasquale - Nephron Research Michael Polark - Wolfe Research Shagun Singh - RBC Capital Markets Richard Newitter - Truist Securities Adam Maeder - Piper Sandler Mike Matson - Needham & ...
Axonics(AXNX) - 2023 Q1 - Earnings Call Transcript
2023-05-02 01:36
Axonics, Inc. (NASDAQ:AXNX) Q1 2023 Earnings Conference Call May 1, 2023 4:30 PM ET Company Participants Neil Bhalodkar - VP of IR Raymond Cohen - CEO Dan Dearen - President and CFO Conference Call Participants Chris Pasquale - Nephron Research Richard Newitter - Truist Securities Nathan Treyback - Wells Fargo Adam Maeder - Piper Sandler Michael Polark - Wolfe Research Shagun Singh - RBC Capital Markets Mike Matson - Needham and Company Anthony Petrone - Mizuho Securities Michael Sarcone - Jefferies Operato ...
Axonics(AXNX) - 2023 Q1 - Quarterly Report
2023-05-01 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________________________________________ FORM 10-Q _________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ ...
Axonics(AXNX) - 2022 Q4 - Earnings Call Transcript
2023-03-02 03:59
Axonics, Inc. (NASDAQ:AXNX) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Neil Bhalodkar - VP of IR Raymond Cohen - CEO Dan Dearen - President and CFO Conference Call Participants Travis Steed - Bank of America Larry Biegelsen - Wells Fargo Chris Pasquale - Nephron Research Cecilia Furlong - Morgan Stanley David Rescott - Truist Adam Maeder - Piper Sandler Michael Polark - Wolfe Research Shagun Singh - RBC Capital Markets Michael Sarcone - Jefferies Mike Matson - Needham and ...
Axonics(AXNX) - 2022 Q4 - Annual Report
2023-02-28 16:00
| --- | --- | |----------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------| | | Commission File Number: 001-38721 _________________________________________________________________ | | (Exact name of | Axonics, Inc. registrant as specified in its charter) _________________________________________________________________ | | Delaware | 45-4744083 | | incorporat ...
Axonics(AXNX) - 2022 Q3 - Earnings Call Transcript
2022-11-01 04:09
Axonics, Inc. (NASDAQ:AXNX) Q3 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Neil Bhalodkar - Vice President of Investor Relations Raymond Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Officer Conference Call Participants Adam Maeder - Piper Sandler Chris Pasquale - Nephron Research Travis Steed - Bank of America Securities David Rescott - Truist Cecilia Furlong - Morgan Stanley Michael Polark - Wolfe Research Mike Matson - Needham & Company Operat ...
Axonics(AXNX) - 2022 Q2 - Earnings Call Transcript
2022-08-02 02:30
Axonics, Inc. (NASDAQ:AXNX) Q2 2022 Earnings Conference Call August 1, 2022 4:30 PM ET Company Participants Neil Bhalodkar - Investor Relations Raymond Cohen - Chief Executive Officer Dan Dearen - President & Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Adam Maeder - Piper Sandler Cecilia Furlong - Morgan Stanley Lawrence Biegelsen - Wells Fargo Securities Mike Polark - Wolfe Research Mike Matson - Needham & Company Operator Good day and thank you for standi ...